
Increase in Rare Health Disorder Linked to Cannabis Use
Cannabinoid Hyperemesis Syndrome (CHS), a condition characterized by nausea, vomiting, and abdominal pain, is increasingly affecting cannabis users, with emergency visits doubling in the U.S. and Canada from 2017 to 2021. The rise is linked to increased cannabis potency and accessibility due to legalization. CHS primarily affects heavy, long-term users and is thought to involve the endocannabinoid system and stress response. Diagnosis requires cannabis cessation, which can be challenging due to withdrawal symptoms. Treatment includes hydration, anti-nausea medications, and potentially quitting cannabis.






